MANE
Veradermics, Inc
$119.60
-5.31 (-4.25%)
At close · Jul 10
Market Cap
$5.00B
Shares
41,778,687
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$119.60
Open$124.47
Day$117.00–125.04
52W$32.00–131.24
Avg vol 30d659K
Short int3.8M · 9.1% float · 3.6d
Short vol64%
Last earningsApr 27, 2026
DataFeb 2026–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+13%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
88%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
2 of 80 funds reported for Jun 30 · net +74 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.12% of float · ▲ +52.9% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
80 holders — 13F breadth
Squeeze score
73
high risk · 0–100
Fundamentals
EPS growth
−202%
Y/Y
Free cash flow
$-71.6M
Balance sheet
$21.8M
net cash
Quant / Vol
risk profile
Volatility
109%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
6.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+13%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
88%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
2 of 80 funds reported for Jun 30 · net +74 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.12% of float · ▲ +52.9% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
80 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $32
Now $120 · 88%
52-wk high $131
vs 50-day avg +13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MANE
this stock
Veradermics, Inc
|
$5.00B | — | — | — | 9.1% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MANE | -7.8% | +28.6% | — | -2.7% | — |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -9.2% | +24.6% | — | -3.8% | — |